223 related articles for article (PubMed ID: 12406886)
1. Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease.
Hofling AA; Vogler C; Creer MH; Sands MS
Blood; 2003 Mar; 101(5):2054-63. PubMed ID: 12406886
[TBL] [Abstract][Full Text] [Related]
2. Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.
Hofling AA; Devine S; Vogler C; Sands MS
Mol Ther; 2004 Jun; 9(6):856-65. PubMed ID: 15194052
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease.
Meyerrose TE; Roberts M; Ohlemiller KK; Vogler CA; Wirthlin L; Nolta JA; Sands MS
Stem Cells; 2008 Jul; 26(7):1713-22. PubMed ID: 18436861
[TBL] [Abstract][Full Text] [Related]
4. [Intra-bone marrow infusion of human cord blood hematopoietic stem/progenitor cells improves hematopoietic reconstitution in NOD-SCID mice].
Meng ZT; Gao JT; Lu SH; Yan X; Li YH; Yang Z; Zheng YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1010-5. PubMed ID: 19698249
[TBL] [Abstract][Full Text] [Related]
5. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity.
Hess DA; Craft TP; Wirthlin L; Hohm S; Zhou P; Eades WC; Creer MH; Sands MS; Nolta JA
Stem Cells; 2008 Mar; 26(3):611-20. PubMed ID: 18055447
[TBL] [Abstract][Full Text] [Related]
6. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
[TBL] [Abstract][Full Text] [Related]
7. Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms.
Barker JE; Schuldt AJ; Lessard MD; Jude CD; Vogler CA; Soper BW
Blood Cells Mol Dis; 2003; 31(2):291-7. PubMed ID: 12972038
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression.
Kosuga M; Takahashi S; Sasaki K; Li XK; Fujino M; Hamada H; Suzuki S; Yamada M; Matsuo N; Okuyama T
Mol Ther; 2000 May; 1(5 Pt 1):406-13. PubMed ID: 10933961
[TBL] [Abstract][Full Text] [Related]
9. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.
Rice AM; Wood JA; Milross CG; Collins CJ; McCarthy NF; Vowels MR
Transplantation; 2000 Mar; 69(5):927-35. PubMed ID: 10755552
[TBL] [Abstract][Full Text] [Related]
10. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
11. Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VII.
Barker JE; Schuldt AJ; Lessard ML; Jude CD; Vogler CA; Soper BW
Exp Hematol; 2003 Nov; 31(11):1112-8. PubMed ID: 14585377
[TBL] [Abstract][Full Text] [Related]
12. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
[TBL] [Abstract][Full Text] [Related]
13. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow.
Wilpshaar J; Noort WA; Kanhai HH; Willemze R; Falkenburg JH
Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407
[TBL] [Abstract][Full Text] [Related]
14. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice.
Kosuga M; Sasaki K; Tanabe A; Li XK; Okawa H; Ogino I; Okuda O; Arai H; Sakuragawa N; Kamata Y; Azuma N; Suzuki S; Yamada M; Okuyama T
Mol Ther; 2001 Feb; 3(2):139-48. PubMed ID: 11237670
[TBL] [Abstract][Full Text] [Related]
15. In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice.
Turner CW; Archer DR; Wong J; Yeager AM; Fleming WH
Br J Haematol; 1998 Nov; 103(2):326-34. PubMed ID: 9827901
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation cell therapy for mucopolysaccharidosis type VII using genetically engineered immortalized human amniotic epithelial cells.
Nakama H; Ohsugi K; Otsuki T; Date I; Kosuga M; Okuyama T; Sakuragawa N
Tohoku J Exp Med; 2006 May; 209(1):23-32. PubMed ID: 16636519
[TBL] [Abstract][Full Text] [Related]
17. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B
Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.
Xu L; Mango RL; Sands MS; Haskins ME; Ellinwood NM; Ponder KP
Mol Ther; 2002 Dec; 6(6):745-58. PubMed ID: 12498771
[TBL] [Abstract][Full Text] [Related]
19. Mucopolysaccharidosis type VII: A powerful experimental system and therapeutic challenge.
Sands MS
Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():159-65. PubMed ID: 25345098
[TBL] [Abstract][Full Text] [Related]
20. A genetically myeloablated MPS VII model detects the expansion and curative properties of as few as 100 enriched murine stem cells.
Soper BW; Duffy TM; Vogler CA; Barker JE
Exp Hematol; 1999 Nov; 27(11):1691-704. PubMed ID: 10560917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
